Stony Brook University
Stony Brook, New York, 11794, United States
NCT Number: NCT03865342
This study will test the weight loss efficacy of a mobile diabetes prevention program intervention. Half of the sample of prediabetic adults will receive the virtual DPP and half will receive usual medical care.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Stony Brook, New York, 11794, United States
There were 84.1 million people with pre-diabetes, 30.3 million people with diagnosed and 7.2 million with undiagnosed diabetes in the United States in 2015, and nearly 2 million are diagnosed with it every year. By 2050, the CDC estimates that 1 in every 3 people globally will have diabetes, a leading cause of death and disability.
The primary goal of this study is to evaluate the efficacy of the Noom Coach Diabetes Prevention Program mobile platform versus usual medical care. The best intervention to date for prediabetes is the Centers for Disease Control and Prevention's Diabetes Prevention Program, yet there is limited research investigating a mobile-based delivery of the DPP. Pre-diabetes is often discovered during routine medical visitation/annual screening (usual care), but face-to-face time with clinicians is often limited. Exploring novel ways, such as mHealth interventions to empower patients to pursue lifestyle change and prevent or delay diabetes onset is critical to addressing the growing diabetes epidemic.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects receiving the smartphone app will receive the DPP core curriculum for 16 weeks and then the post-core curriculum for 36 weeks through the app. The Noom mobile app allows secure patient monitoring through a participant dashboard that the coach can use to increase patient adherence and motivation to achieve DPP goals. The participant can log their food intake, weight, steps, exercise, in addition to participating in the DPP group interaction through the application.
Time frame: Baseline, 6, and 12 months
Body weight recorded during follow-up appointments at the medical clinic.
Time frame: Baseline, 6, and 12 months
Hemoglobin A1c measured during follow-up appointments at the medical clinic.
Time frame: Baseline, 6, and 12 months
Work Productivity and Activity Impairment Questionnaire: General Health V2.0 (WPAI)
Time frame: Baseline, 6, and 12 months
Healthy Days Core Module (CDC HRQOL- 4)
Noom Inc.
Industry
Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention (DPP) Program: a Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05056376
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial DetailsNCT02063048
Body Weight, Body Weight Changes
Denver, Colorado, United States
View Trial DetailsNCT07713394
Behavior, Body Weight
Erzurum, Turkey, Turkey (Türkiye)
View Trial DetailsNCT04745572
Behavior, Body Weight
Birmingham, Alabama, United States
View Trial Details